Volume 17, Issue 8 e202400007
RESEARCH ARTICLE

Measurement of anisotropy factor of nanoparticle embedded tumor phantoms for plasmonic photothermal therapeutics

Vikas

Vikas

Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India

Biomedical Applications Group, CSIR—Central Scientific Instruments Organisation, Chandigarh, India

Search for more papers by this author
Raj Kumar

Raj Kumar

Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India

Micro and Nano Optics Centre, CSIR—Central Scientific Instruments Organisation, Chandigarh, India

Search for more papers by this author
Sanjeev Soni

Corresponding Author

Sanjeev Soni

Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India

Biomedical Applications Group, CSIR—Central Scientific Instruments Organisation, Chandigarh, India

Correspondence

Sanjeev Soni, Biomedical Applications Group, CSIR—Central Scientific Instruments Organisation, Sector-30C, Chandigarh 160030, India.

Email: [email protected]

Search for more papers by this author
First published: 18 June 2024

Abstract

Measurement of anisotropy factor (g) in the presence of nanoparticles (NPs) is important for understanding light distribution for plasmonic photothermal cancer therapeutics. Here, anisotropy factor is investigated through bilayer phantoms (epidermal and dermal) of various thicknesses incorporated with gold nanorods (GNRs) concentrations of 10–40 μg/mL by using in-house developed goniometric setup. Results show that 10 μg/mL GNRs in the phantom increase g by ~50% (g = 0.9471) w.r.t. phantom without NPs. Higher concentrations (40 μg/mL) of GNRs decrease g by ~43% (g = 0.5341) w.r.t. phantom with 10 μg/mL GNRs. For 40 μg/mL GNRs phantom, the anisotropy factor reduces by 47% for phantom thickness from 600 to 1800 μm. Anisotropy factor of GNR embedded phantom increased by 44% by using glycerol (10%–40%). Incorporation of NPs in a tumor significantly affects g, a major parameter for light distribution. These measurements provide insights for light scattering based on nanoparticle doses for plasmonic photothermal therapeutics.image

CONFLICT OF INTEREST STATEMENT

The authors declare no financial or commercial conflict of interest.

DATA AVAILABILITY STATEMENT

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.